Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports. Fain ET, Mannion M, Pope E, Young DW, Laxer RM, Cron RQ. Pediatr Rheumatol Online J. 2011 Jul 29;9:18. PMID: 21801349


Sarcoidosis in a young child with Alagille syndrome: a case report. Mannion M, Zolak M, Kelly DR, Beukelman T, Cron RQ. Pediatr Rheumatol Online J. 2012 Aug 31;10(1):32. PMID: 22937766


Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. Kahn PJ, Cron RQ. J Rheumatol. 2013 May;40(5):743-4. PMID: 23637382

Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report. Donnithorne KJ, Read RW, Lowe R, Weiser P, Cron RQ, Beukelman T. Pediatr Rheumatol Online J. 2013 Jun 4;11(1):25. PMID: 23734963

High doses of infliximab in the management of juvenile idiopathic arthritis. Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML. J Rheumatol. 2013 Oct;40(10):1749-55. PMID: 23950184

2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Ringold S, Weiss PF, Beukelman T, Dewitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK; American College of Rheumatology. Arthritis Care Res (Hoboken). 2013 Oct;65(10):1551-63. PMID: 24078300

Treatment of juvenile idiopathic arthritis in the biologic age. Stoll ML, Cron RQ. Rheum Dis Clin North Am. 2013 Nov;39(4):751-66. PMID: 24182853



Treatment advances in systemic juvenile idiopathic arthritis. Beukelman T. F1000Prime Rep. 2014 Apr 1;6:21. PMID: 24765526

Treatment of juvenile idiopathic arthritis: a revolution in care. Stoll ML, Cron RQ. Pediatr Rheumatol Online J. 2014 Apr 23;12:13. PMID: 24782683

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report. Shafferman A, Birmingham JD, Cron RQ. Pediatr Rheumatol Online J. 2014 Jul 11;12:26. PMID: 25045337

Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors. Mannion ML, Xie F, Curtis JR, Beukelman T. J Rheumatol. 2014 Oct;41(10):2078-84. PMID: 25086081


Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases. Tambralli A, Beukelman T, Cron RQ, Stoll ML. J Rheumatol. 2015 Mar;42(3):541-6. PMID: 25593242

Kill or be killed. Behrens EM, Cron RQ. J Immunol. 2015 Jun 1;194(11):5041-3. PMID: 25980027

Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis. Stoll ML, Vaid YN, Guleria S, Beukelman T, Waite PD, Cron RQ. J Rheumatol. 2015 Nov;42(11):2155-9. PMID: 26329345


Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM. Crit Care Med. 2016 Feb;44(2):275-81. PMID: 26584195

Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis. Mannion ML, McAllister L, Cron RQ, Stoll ML. J Clin Rheumatol. 2016 Aug;22(5):282-4. PMID: 27464779


Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance. Horton DB, Onel KB, Beukelman T, Ringold S. J Rheumatol. 2017 Mar;44(3):352-360. PMID: 28148696

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans. Kimura Y, Grevich S, Beukelman T, Morgan E, Nigrovic PA, Mieszkalski K, Graham TB, Ibarra M, Ilowite N, Klein-Gitelman M, Onel K, Prahalad S, Punaro M, Ringold S, Toib D, Van Mater H, Weiss JE, Weiss PF, Schanberg LE; CARRA Registry Investigators. Pediatr Rheumatol Online J. 2017 Apr 11;15(1):23. PMID: 28399931

Biologic therapy modifies clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, Kone-Paut I, Kostik M, Lovell D, Maritsi D, Nigrovic PA, Pal P, Ravelli A, Shimizu M, Stanevicha V, Vastert S, Woerner A, de Benedetti F, Grom AA. Arthritis Care Res (Hoboken). 2017 May 12. [Epub ahead of print]. PMID: 28499329

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. Spencer CH, Rouster-Stevens K, Gewanter H, Syverson G, Modica R, Schmidt K, Emery H, Wallace C, Grevich S, Nanda K, Zhao YD, Shenoi S, Tarvin S, Hong S, Lindsley C, Weiss JE, Passo M, Ede K, Brown A, Ardalan K, Bernal W, Stoll ML, Lang B, Carrasco R, Agaiar C, Feller L, Bukulmez H, Vehe R, Kim H, Schmeling H, Gerstbacher D, Hoeltzel M, Eberhard B, Sundel R, Kim S, Huber AM, Patwardhan A; Pediatric Rheumatologist Collaborators. Pediatr Rheumatol Online J. 2017 Jun 13;15(1):50. PMID: 28610606

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis. Falvey S, Shipman L, Ilowite N, Beukelman T. Pediatr Rheumatol Online J. 2017 Jun 19;15(1):52. PMID: 28629458

Weathering a Macrophage Storm. Crayne CB, Cron RQ. J Rheumatol. 2017 Jul;44(7):970-972. PMID: 28668814

Biologic Agents in the Treatment of Childhood-Onset Rheumatic Disease. Mehta J, Beukelman T. J Pediatr. 2017 Jul 13. [Epub ahead of print]. PMID: 28711176